Foetal vascular responses to thromboxane receptor blockade
We hypothesized that foetal administration of SQ-29,548, a putative thromboxane receptor blocker, would prevent foeto–placental vasoconstriction produced by the thromboxane mimic U46619. Arterial blood gases, continuous monitoring of maternal and foetal heart rates and blood pressures were performed...
Saved in:
Main Authors: | B. A. Meyer, J. E. Dickinson, S. W. Walsh, V. M. Parisi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1992-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/S0962935192000048 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blockade of Vascular Endothelial Growth Factor
Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
by: Jianbo He, et al.
Published: (2015-01-01) -
Foetal Macrosomia and Foetal-Maternal Outcomes at Birth
by: Sahruh Turkmen, et al.
Published: (2018-01-01) -
Downregulation of Thromboxane A2 Receptor Occurs Mainly via Nuclear Factor-KappaB Signaling Pathway in Rat Renal Artery
by: Yaping Zhang, et al.
Published: (2017-01-01) -
Foetal Haemoglobin, Erythrocytes Containing Foetal Haemoglobin, and Hematological Features in Congolese Patients with Sickle Cell Anaemia
by: L. Tshilolo, et al.
Published: (2012-01-01) -
Mas Receptor Blockade Promotes Renal Vascular Response to Ang II after Partial Kidney Ischemia/Reperfusion in a Two-Kidney-One-Clip Hypertensive Rats Model
by: Farzaneh Karimi, et al.
Published: (2021-01-01)